Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Honeywell
HON
$77.9B
| $523M | 0.31% |
2,648,509
-67,665
| -2% | -$12.2M |
|
77
Corteva
CTVA
$58.6B
| $521M | 0.31% |
10,865,604
+92,170
| +0.9% | +$4.4M |
|
78
TFI International
TFII
$12B
| $516M | 0.31% |
3,791,235
+512,573
| +16% | +$60.7M |
|
79
Sarepta Therapeutics
SRPT
$1.68B
| $515M | 0.31% |
5,345,785
-436,664
| -8% | -$41.9M |
|
80
Zoetis
ZTS
$32.2B
| $515M | 0.31% |
2,608,563
-511,157
| -16% | -$90.5M |
|
81
Synopsys
SNPS
$74.5B
| $510M | 0.3% |
991,324
+69,247
| +8% | +$35.4M |
|
82
Microchip Technology
MCHP
$42.3B
| $508M | 0.3% |
5,634,530
+136,789
| +2% | +$11.1M |
|
83
Freeport-McMoran
FCX
$90.2B
| $508M | 0.3% |
11,927,173
-440,631
| -4% | -$16.3M |
|
84
Nice
NICE
$5.57B
| $507M | 0.3% |
2,543,507
+36,827
| +1% | +$6.62M |
|
85
Ascendis Pharma A/S
ASND
$16.6B
| $503M | 0.3% |
3,994,785
+140,252
| +4% | +$14M |
|
86
Hilton Worldwide
HLT
$75.3B
| $500M | 0.3% |
2,744,568
-160,422
| -6% | -$26.2M |
|
87
Alliant Energy
LNT
$19.1B
| $492M | 0.29% |
9,594,512
+1,520,528
| +19% | +$75.8M |
|
|
88
TE Connectivity
TEL
$60.2B
| $491M | 0.29% |
3,496,636
-2,841,941
| -45% | -$366M |
|
89
Lamar Advertising Co
LAMR
$16.3B
| $488M | 0.29% |
4,594,103
-31,900
| -0.7% | -$3M |
|
90
Intuit
INTU
$83.1B
| $480M | 0.29% |
767,742
+13,908
| +2% | +$7.67M |
|
91
Costco
COST
$422B
| $475M | 0.28% |
718,897
-8,738
| -1% | -$5.18M |
|
|
92
Atlassian
TEAM
$24.3B
| $471M | 0.28% |
1,981,448
-1,531,791
| -44% | -$301M |
|
93
ConocoPhillips
COP
$141B
| $469M | 0.28% |
4,039,852
-441,509
| -10% | -$51.7M |
|
94
Alphabet (Google) Class A
GOOGL
$3.99T
| $463M | 0.28% |
3,314,865
+14,855
| +0.5% | +$2M |
|
95
Rentokil
RTO
$14.4B
| $459M | 0.27% |
16,034,476
+412,546
| +3% | +$12.1M |
|
96
Starbucks
SBUX
$118B
| $457M | 0.27% |
4,755,431
+3,432
| +0.1% | +$334K |
|
97
American Tower
AMT
$77.7B
| $456M | 0.27% |
2,114,032
-7,566
| -0.4% | -$1.43M |
|
98
Broadcom
AVGO
$1.82T
| $446M | 0.27% |
3,991,340
+1,560,530
| +64% | +$148M |
|
99
Steris
STE
$21.3B
| $441M | 0.26% |
2,005,018
-91,046
| -4% | -$19.3M |
|
100
Caesars Entertainment
CZR
$6.1B
| $440M | 0.26% |
9,383,462
-1,486,889
| -14% | -$66M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.